The Scantox Neuro Symposium 2026 – Boston will bring together scientists working across neurodegeneration, translational biology, preclinical development, and CNS drug discovery for a focused half-day program in Cambridge.
Our presenters will cover practical questions around model selection, neuroinflammation, translational biomarkers, NAMs, in vivo models, and how preclinical data can better inform human endpoints.
Who should attend?
Scientists and R&D leaders from biotech, pharma, and neuroscience organizations working on:
• Alzheimer’s, Parkinson’s, and other neurodegenerative diseases
• CNS target validation and efficacy studies
• Translational biomarkers and disease mechanisms
• Human-relevant in vitro and NAM approaches
• In vivo model selection and preclinical strategy
• Early-stage therapeutic development
📅 October 13, 2026
📍 MassBioHub, Cambridge, MA
☕ Registration from 8:30 AM | Program from 9:00 AM
Explore the agenda and register here:
